Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
QIVe is an egg-based quadrivalent influenza vaccine designed to prevent test-confirmed influenza. It is manufactured using a traditional process where influenza viruses are grown in fertilized chicken eggs. This vaccine targets four different influenza virus strains. Studies frequently compare its effectiveness to cell-based quadrivalent influenza vaccines (QIVc) and adjuvanted or high-dose quadrivalent influenza vaccines (aQIV/HD-QIV). A notable characteristic is that egg adaptation during the manufacturing process can sometimes reduce its effectiveness compared to cell-based alternatives. QIVe is indicated for use in various age groups, including children and adults, for seasonal influenza prevention.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on QIVe.